ArticleImmunotherapy2025

Durable response to an anti-CD25 antibody-drug conjugate and anti-PD-1 antibody in ovarian carcinoma: a case report.

Faraah Bekheet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.